A high-throughput O-glycopeptide discovery platform for seromic profiling.

Biomarker microarrays are becoming valuable tools for serological screening of disease-associated autoantibodies. Post-translational modifications (PTMs) such as glycosylation extend the range of protein function, and a variety of glycosylated proteins are known to be altered in disease progression. Here, we have developed a synthetic screening microarray platform for facile display of O-glycosylated peptides (O-PTMs). By introduction of a capping step during chemical solid-phase glycopeptide synthesis, selective enrichment of N-terminal glycopeptide end products was achieved on an amine-reactive hydrogel-coated microarray glass surface, allowing high-throughput display of large numbers of glycopeptides. Utilizing a repertoire of recombinant glycosyltransferases enabled further diversification of the array libraries in situ and display of a new level of potential biomarker candidates for serological screening. As proof-of-concept, we have demonstrated that MUC1 glycopeptides could be assembled and used to detect autoantibodies in vaccine-induced disease-free breast cancer patients and in patients with confirmed disease at time of diagnosis.

[1]  M. Hollingsworth,et al.  Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. , 2010, Cancer research.

[2]  M. Tainsky,et al.  Genomic and proteomic biomarkers for cancer: a multitude of opportunities. , 2009, Biochimica et biophysica acta.

[3]  S. Nishimura,et al.  An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library. , 2009, Journal of the American Chemical Society.

[4]  L. Tabak,et al.  Isoform-specific O-Glycosylation of Osteopontin and Bone Sialoprotein by Polypeptide N-Acetylgalactosaminyltransferase-1* , 2009, The Journal of Biological Chemistry.

[5]  H. Waldmann,et al.  Tumor-associated MUC1 tandem-repeat glycopeptide microarrays to evaluate serum- and monoclonal-antibody specificity. , 2009, Angewandte Chemie.

[6]  J. Solassol,et al.  Humoral response to cancer as a tool for biomarker discovery. , 2009, Journal of proteomics.

[7]  J. Solassol,et al.  Identifying autoantibody signatures in cancer: a promising challenge , 2009, Expert review of proteomics.

[8]  N. Wentzensen,et al.  A systematic review of humoral immune responses against tumor antigens , 2009, Cancer Immunology, Immunotherapy.

[9]  Maja Köhn,et al.  Immobilization strategies for small molecule, peptide and protein microarrays , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[10]  J. Gildersleeve,et al.  Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. , 2009, Journal of proteome research.

[11]  Y. Hiki O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy , 2009, Clinical and Experimental Nephrology.

[12]  J. Holgersson,et al.  Anticarbohydrate Antibody Repertoires in Patients Transplanted with Fetal Pig Islets Revealed by Glycan Arrays , 2009 .

[13]  S. Gaskell,et al.  SPOT Synthesis of Peptide Arrays on Self‐Assembled Monolayers and their Evaluation as Enzyme Substrates , 2008, Chembiochem : a European journal of chemical biology.

[14]  M. Uttamchandani,et al.  Peptide microarrays: next generation biochips for detection, diagnostics and high-throughput screening. , 2008, Current pharmaceutical design.

[15]  E. Tan,et al.  Autoantibodies to tumor‐associated antigens: reporters from the immune system , 2008, Immunological reviews.

[16]  A. Iasonos,et al.  Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer , 2007, Clinical Cancer Research.

[17]  R. Westhovens,et al.  Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. , 2007, Clinical chemistry.

[18]  J. Taylor‐Papadimitriou,et al.  Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat. , 2007, Glycobiology.

[19]  Ola Blixt,et al.  Glycan microarrays for screening sialyltransferase specificities , 2007, Glycoconjugate Journal.

[20]  Thomas Norberg,et al.  Pathogen specific carbohydrate antigen microarrays: a chip for detection of Salmonella O-antigen specific antibodies , 2007, Glycoconjugate Journal.

[21]  P. Azadi,et al.  A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen , 2006, Science.

[22]  Sudhir Srivastava,et al.  Posttranslational Protein Modifications , 2006, Molecular & Cellular Proteomics.

[23]  R. Bayer,et al.  GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli. , 2006, Glycobiology.

[24]  R. Stahn,et al.  PankoMab: a potent new generation anti-tumour MUC1 antibody , 2006, Cancer Immunology, Immunotherapy.

[25]  M. Hollingsworth,et al.  Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. , 2006, Glycobiology.

[26]  Joshua LaBaer,et al.  On-chip protein synthesis for making microarrays. , 2006, Methods in molecular biology.

[27]  Chi-Huey Wong,et al.  Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Leszek Rychlewski,et al.  Target specificity analysis of the Abl kinase using peptide microarray data. , 2004, Journal of molecular biology.

[29]  J. Taylor‐Papadimitriou,et al.  MUC1 and the Immunobiology of Cancer , 2002, Journal of mammary gland biology and neoplasia.

[30]  L. Tabak,et al.  Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide α-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates , 1996, Glycoconjugate Journal.

[31]  P. Roepstorff,et al.  Development and characterization of an antibody directed to an α-N-acetyl-D-galactosamine glycosylated MUC2 peptide , 2004, Glycoconjugate Journal.

[32]  H. Kunz,et al.  Synthesis of Tumor‐Associated Glycopeptide Antigens , 2002 .

[33]  S. Hakomori,et al.  Glycosylation defining cancer malignancy: New wine in an old bottle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Peter Roepstorff,et al.  Functional Conservation of Subfamilies of Putative UDP-N-acetylgalactosamine:Polypeptide N-Acetylgalactosaminyltransferases inDrosophila, Caenorhabditis elegans, and Mammals , 2002, The Journal of Biological Chemistry.

[35]  P. Brown,et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.

[36]  M. Hollingsworth,et al.  The Lectin Domain of UDP-N-acetyl-d-galactosamine:PolypeptideN-acetylgalactosaminyltransferase-T4 Directs Its Glycopeptide Specificities* , 2000, The Journal of Biological Chemistry.

[37]  M. Price,et al.  Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n‐acetylgalactosamine (GalNAc) peptides , 2000, International journal of cancer.

[38]  W. Chan,et al.  Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Practical Approach Series) , 2019 .

[39]  I. Brockhausen Pathways of O-glycan biosynthesis in cancer cells. , 1999, Biochimica et biophysica acta.

[40]  M. Hollingsworth,et al.  Cloning and Characterization of a Close Homologue of Human UDP-N-acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase-T3, Designated GalNAc-T6 , 1999, The Journal of Biological Chemistry.

[41]  M. Hollingsworth,et al.  Cloning of a Human UDP-N-Acetyl-α-d-Galactosamine:PolypeptideN-Acetylgalactosaminyltransferase That Complements Other GalNAc-Transferases in Complete O-Glycosylation of the MUC1 Tandem Repeat* , 1998, The Journal of Biological Chemistry.

[42]  O. Blixt,et al.  Solid-Phase Enzymatic Synthesis of a Sialyl Lewis X Tetrasaccharide on a Sepharose Matrix. , 1998, The Journal of organic chemistry.

[43]  O. Nilsson,et al.  Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 Mucin , 1997, Tumor Biology.

[44]  M. Hollingsworth,et al.  Substrate Specificities of Three Members of the Human UDP-N-Acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase Family, GalNAc-T1, -T2, and -T3* , 1997, The Journal of Biological Chemistry.

[45]  G. Springer Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy , 1997, Journal of Molecular Medicine.

[46]  B. Meyer,et al.  Synthesis and characterisation of highly glycosylated glycopeptides with Tn-antigenic structures corresponding to human glycophorin AN. , 1997, Carbohydrate research.

[47]  J. Kihlberg,et al.  Direct synthesis of glycosylated amino acids from carbohydrate peracetates and Fmoc amino acids: solid-phase synthesis of biomedicinally interesting glycopeptides. , 1997, Methods in enzymology.

[48]  E. Bennett,et al.  A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. , 1996, Glycobiology.

[49]  M. Meldal,et al.  Synthesis of the glycosyl amino acids Nα-Fmoc-Ser[Ac4-β-d-Gal p-(1 → 3)-Ac2-α-d-GalN3 p]-OPfp and Nα-Fmoc-Thr[Ac4-β-d-Gal p-(1 → 3)-Ac2-α-d-GalN3 p]-OPfp and the application in the solid-phase peptide synthesis of multiply glycosylated mucin peptides with Tn and T antigenic structures , 1995 .

[50]  S. Hirohashi,et al.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. , 1988, Cancer research.

[51]  H. Paulsen,et al.  Synthese der glycopeptide O-β-d-galactopyranosyl-(1→3)-O-(2-acetamido-2-desoxy-α-d-galactopyranosyl)-(1→3)-l-serin und -l-threonin , 1982 .

[52]  H. Paulsen,et al.  [Synthesis of the glycopeptide O-beta-D-galactopyranosyl-(1 to 3)-O-(2-acetamido-2-desoxy-alpha-D-galactopyranosyl)-(1 to 3)-L-serine and -L-threonine]. , 1982, Carbohydrate research.